IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 125 filers reported holding IMMUNOVANT INC in Q1 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,151,068 | +81.2% | 56,032 | -10.5% | 0.00% | +100.0% |
| Q2 2023 | $1,187,408 | +51.9% | 62,594 | +24.2% | 0.00% | 0.0% |
| Q1 2023 | $781,734 | -10.0% | 50,402 | +3.0% | 0.00% | 0.0% |
| Q4 2022 | $868,171 | +285.9% | 48,911 | +21.4% | 0.00% | – |
| Q3 2022 | $225,000 | +55.2% | 40,279 | +8.8% | 0.00% | – |
| Q2 2022 | $145,000 | -24.5% | 37,013 | +6.1% | 0.00% | – |
| Q1 2022 | $192,000 | -4.0% | 34,873 | +48.6% | 0.00% | – |
| Q4 2021 | $200,000 | +7.5% | 23,460 | +9.4% | 0.00% | – |
| Q3 2021 | $186,000 | -74.3% | 21,440 | -68.7% | 0.00% | – |
| Q2 2021 | $724,000 | -6.6% | 68,579 | +42.0% | 0.00% | – |
| Q1 2021 | $775,000 | -74.4% | 48,312 | -26.4% | 0.00% | -100.0% |
| Q4 2020 | $3,029,000 | +120.1% | 65,604 | +67.8% | 0.00% | 0.0% |
| Q3 2020 | $1,376,000 | +323.4% | 39,086 | +192.2% | 0.00% | – |
| Q2 2020 | $325,000 | – | 13,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,717,182 | $139,213,000 | 3.92% |
| Ghost Tree Capital, LLC | 525,000 | $12,784,000 | 3.37% |
| Logos Global Management LP | 625,000 | $15,219,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 350,000 | $8,523,000 | 2.46% |
| BVF INC/IL | 1,088,479 | $26,504,000 | 1.63% |
| Vivo Capital, LLC | 800,000 | $19,480,000 | 1.40% |
| Camber Capital Management LP | 800,000 | $19,480,000 | 1.12% |
| Sio Capital Management, LLC | 152,450 | $3,712,000 | 1.08% |
| Prosight Management, LP | 95,500 | $2,325,000 | 1.00% |
| Parkman Healthcare Partners LLC | 125,125 | $3,047,000 | 0.86% |